- Home
- NRSN vs DALN Comparison
NRSN vs DALN Comparison
Compare NRSN & DALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- DALN
- Stock Information
- Founded
- NRSN 2017
- DALN 1954
- Country
- NRSN Israel
- DALN United States
- Employees
- NRSN N/A
- DALN N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- DALN Newspapers/Magazines
- Sector
- NRSN Health Care
- DALN Consumer Discretionary
- Exchange
- NRSN Nasdaq
- DALN Nasdaq
- Market Cap
- NRSN 26.3M
- DALN 29.3M
- IPO Year
- NRSN 2021
- DALN 2008
- Fundamental
- Price
- NRSN $1.31
- DALN $5.11
- Analyst Decision
- NRSN
- DALN
- Analyst Count
- NRSN 0
- DALN 0
- Target Price
- NRSN N/A
- DALN N/A
- AVG Volume (30 Days)
- NRSN 181.1K
- DALN 38.5K
- Earning Date
- NRSN 11-26-2024
- DALN 11-12-2024
- Dividend Yield
- NRSN N/A
- DALN 12.26%
- EPS Growth
- NRSN N/A
- DALN N/A
- EPS
- NRSN N/A
- DALN N/A
- Revenue
- NRSN N/A
- DALN $128,286,000.00
- Revenue This Year
- NRSN N/A
- DALN N/A
- Revenue Next Year
- NRSN N/A
- DALN N/A
- P/E Ratio
- NRSN N/A
- DALN N/A
- Revenue Growth
- NRSN N/A
- DALN N/A
- 52 Week Low
- NRSN $0.47
- DALN $2.98
- 52 Week High
- NRSN $2.33
- DALN $6.47
- Technical
- Relative Strength Index (RSI)
- NRSN 61.44
- DALN 50.60
- Support Level
- NRSN $1.23
- DALN $5.05
- Resistance Level
- NRSN $1.34
- DALN $6.47
- Average True Range (ATR)
- NRSN 0.10
- DALN 0.50
- MACD
- NRSN 0.01
- DALN -0.04
- Stochastic Oscillator
- NRSN 75.00
- DALN 30.26
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About DALN DallasNews Corporation Series A
DallasNews Corp is a local news and information publishing company in Texas with commercial printing, distribution, and direct mail capabilities, as well as a presence in emerging media and digital marketing.